Evidence map›Paper›PMID 28634212›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2017

Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR-200b down-regulation.

Nan Wu, Fanyin Meng, Tianhao Zhou, Yuyan Han, Lindsey Kennedy, Julie Venter, Heather Francis, Sharon DeMorrow, Paolo Onori, Pietro Invernizzi and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. The Role of microRNAs in Cholangiocarcinoma.International journal of molecular sciences · 2021
    Review
  10. Observational
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Possible application of melatonin treatment in human diseases of the biliary tract.American journal of physiology. Gastrointestinal and liver physiology · 2019
    Review
  20. Protective role of melatonin in early-stage and end-stage liver cirrhosis.Journal of cellular and molecular medicine · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Nan WuDivision of Gastroenterology, Department of Medicine, Texas A&M University Health Science Center, Temple, Texas, USA.
Fanyin MengDivision of Gastroenterology, Department of Medicine, Texas A&M University Health Science Center, Temple, Texas, USA.
Tianhao ZhouDivision of Gastroenterology, Department of Medicine, Texas A&M University Health Science Center, Temple, Texas, USA.
Yuyan HanDivision of Gastroenterology, Department of Medicine, Texas A&M University Health Science Center, Temple, Texas, USA.
Lindsey KennedyDivision of Gastroenterology, Department of Medicine, Texas A&M University Health Science Center, Temple, Texas, USA.
Julie VenterDivision of Gastroenterology, Department of Medicine, Texas A&M University Health Science Center, Temple, Texas, USA.
Heather FrancisDivision of Gastroenterology, Department of Medicine, Texas A&M University Health Science Center, Temple, Texas, USA.
Sharon DeMorrowDivision of Gastroenterology, Department of Medicine, Texas A&M University Health Science Center, Temple, Texas, USA.
Paolo OnoriDepartment of Anatomical, Histological, and Forensic Medicine and Orthopedic Sciences, La Sapienza, Rome, Italy.
Pietro InvernizziCenter for Autoimmune Liver Diseases, Humanitas Clinical and Research Center, Rozzano, Italy.
Francesca BernuzziCenter for Autoimmune Liver Diseases, Humanitas Clinical and Research Center, Rozzano, Italy.
Romina MancinelliDepartment of Anatomical, Histological, and Forensic Medicine and Orthopedic Sciences, La Sapienza, Rome, Italy.
Eugenio GaudioDepartment of Anatomical, Histological, and Forensic Medicine and Orthopedic Sciences, La Sapienza, Rome, Italy.
Antonio FranchittoEleonora Lorillard Spencer Cenci Foundation, Rome, Italy.
Shannon GlaserDivision of Gastroenterology, Department of Medicine, Texas A&M University Health Science Center, Temple, Texas, USA; sglaser@medicine.tamhsc.edu.
Gianfranco AlpiniDivision of Gastroenterology, Department of Medicine, Texas A&M University Health Science Center, Temple, Texas, USA; galpini@tamu.edu.
Texas A&M University · USSapienza University of Rome · ITBaylor Scott & White Medical Center - Temple · USHumanitas University · ITTemple College · US

Funding

GROWTH REGULATION OF THE INTRAHEPATIC BILIARY TREER01DK054811 · NIDDK · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI ALPINI, GIANFRANCO D, GLASER, SHANNON STROUD · 2000 to 2021
$3.8M
Dysregulation of hypothalamic neuropeptides is associated with biliary hyperplasiaR01DK082435 · NIDDK · UNIVERSITY OF TEXAS AT AUSTIN · PI DEMORROW, SHARON · 2010 to 2020
$2.7M
The Paracrine Regulation of Mast Cells During Biliary/Cholangiocyte Repair and DamageR01DK108959 · NIDDK · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI FRANCIS, HEATHER L · 2016 to 2024
$2.5M
Regulation of Bile Duct Growth in Bile Duct Ligated RatsR01DK062975 · NIDDK · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI ALPINI, GIANFRANCO D, GLASER, SHANNON STROUD · 2005 to 2014
$1.9M
Role of Sensory Neuropeptides in the Regulation of Biliary FunctionR01DK076898 · NIDDK · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI ALPINI, GIANFRANCO D, GLASER, SHANNON STROUD · 2008 to 2016
$1.8M
The Role of Stem Cell Derived Microvesicles in Cholestatic Liver InjuryR01DK107310 · NIDDK · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI ALPINI, GIANFRANCO D, GLASER, SHANNON STROUD · 2015 to 2019
$1.7M
Neuroendocrine Regulation of Biliary Growth and FibrosisR01DK110035 · NIDDK · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI ALPINI, GIANFRANCO D, GLASER, SHANNON STROUD · 2017 to 2020
$1.2M
Regulation of biliary growth and fibrosis by melatoninR01DK115184 · NIDDK · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI ALPINI, GIANFRANCO D, GLASER, SHANNON STROUD · 2017 to 2020
$1.2M
REGULATION OF CELLULAR SENESCENCE BY NON-CODING RNAS IN ALCOHOLIC LIVER INJURYR21AA025997 · NIAAA · SCOTT AND WHITE MEMORIAL HOSPITAL · PI ALPINI, GIANFRANCO D, MENG, FANYIN · 2017 to 2018
$435k
Role of stem cell derived microvesicles in alcoholic liver injuryR21AA025157 · NIAAA · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI ALPINI, GIANFRANCO D, MENG, FANYIN · 2017 to 2018
$350k
Mechanisms of synergistic regulation of biliary inflammation and fibrosisI01BX003031 · VA · RLR VA MEDICAL CENTER · PI FRANCIS, HEATHER L · 2016 to 2023
–
The role of hypothalamic neuropeptides on biliary function during cholestasisI01BX002638 · VA · OLIN TEAGUE VETERANS CENTER · PI DEMORROW, SHARON · 2015 to 2018
–
BLRD VA I01 BX000574BLRD VA I01 BX001724BLRD VA I01 BX002192BLRD VA I01 BX002638BLRD VA I01 BX003031NIAAA NIH HHS R21 AA025157NIAAA NIH HHS R21 AA025997NIDDK NIH HHS R01 DK054811NIDDK NIH HHS R01 DK062975NIDDK NIH HHS R01 DK076898NIDDK NIH HHS R01 DK082435NIDDK NIH HHS R01 DK107310NIDDK NIH HHS R01 DK108959NIDDK NIH HHS R01 DK110035NIDDK NIH HHS R01 DK115184
6 · The paper itself

Abstract

Melatonin therapy or prolonged exposure to complete darkness reduces biliary hyperplasia and liver fibrosis in bile-duct-ligated (BDL) rats; however, no information exists in primary sclerosing cholangitis (PSC). Thus, we aimed to determine the therapeutic effects of prolonged dark therapy or melatonin administration on hepatic fibrosis in the multidrug resistance gene 2-knockout (Mdr2

Indexed as

DarknessAngiogenesis Inducing AgentsAnimalsCell ProliferationCholangitis, SclerosingDisease Models, AnimalDown-RegulationFibrosisHepatic Stellate CellsLiver CirrhosisMaleMelatoninMice, TransgenicMicroRNAsAngiogenesis Inducing AgentsMelatoninMicroRNAsMirn200 microRNA, mouseangiogenesisbiliary epitheliumcholangiopathycholestasismiRNA

Identifiers

PMID28634212
PMCPMC5987749
OpenAlexW2678799679

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.